FDA
-
-
-
-
-
-
-
Adagio Medical reports positive pivotal trial results for heart device
-
-
-
-
-
-
-
Adagio Medical Ultralow Temperature Ablation U.S. Pivotal Study Results to be Presented in Late-Breaking Session at Heart Rhythm Society 2026
-
-
-
-
-
-
-
New Adagio Medical Publication Highlights Consistent Safety and Effectiveness with Ultralow Temperature Ablation in Broad Range of Patients with Ventricular Tachycardia
-
-
-
-
-
-
-
Adagio Medical Reports Third Quarter 2025 Results
-
-
-
-
-
-
-
Adagio Medical completes enrollment for pivotal trial of VT device
-
-
-
-
-
-
-
Adagio Medical Reports First Quarter 2025 Results
-
-
-
-
-
-
-
Adagio Medical Announces Appointment of Accomplished Medical Device Leader Todd Usen as Chief Executive Officer and Director
-
328,603 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

